BCYC — BICYCLE THERAPEUTICS PLC

Ownership history in Rangeley Capital, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Rangeley Capital, LLC reported a position in BICYCLE THERAPEUTICS PLC (BCYC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.87% (2025 Q3)
Avg. % of fund
0.76%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 132,000 +2,000 +1.5% 0.78% $935K $7.08
2025 Q3 ADDED 130,000 +55,000 +73.3% 0.87% $1.0M $7.74
2025 Q2 INITIATED 75,000 — — 0.62% $521K $6.95
% of Fund (quarterly)    BCYC price (monthly, adj. close)

Other funds also holding BCYC

As of 2025 Q4 — sorted by position size

FCPM III SERVICES B.V. 3.22% Birchview Capital, LP 3Y 7Y 1.92% GSK plc 1.36% FLAX POND CAPITAL, LLC 0.91% BAKER BROS. ADVISORS LP 3Y 7Y 0.45% MONIMUS CAPITAL MANAGEMENT, LP 0.44% Nan Fung Group Holdings Ltd 3Y 0.44% Siren, L.L.C. 0.43% Long Focus Capital Management, LLC 3Y 0.3% PLATINUM INVESTMENT MANAGEMENT LTD 3Y 7Y 0.3%
← Back to Rangeley Capital, LLC Holdings